Provided by Tiger Trade Technology Pte. Ltd.

LUYE PHARMA

2.130
-0.015-0.70%
Volume:34.01M
Turnover:72.75M
Market Cap:8.51B
PE:11.51
High:2.195
Open:2.145
Low:2.095
Close:2.145
52wk High:3.940
52wk Low:1.730
Shares:4.00B
HK Float Shares:4.00B
Volume Ratio:0.74
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.185
ROE:4.14%
ROA:2.44%
PB:0.45
PE(LYR):11.51
PS:1.16

Loading ...

Movement Alert|Luye Pharma Rises 5.91% in Regular Trading, UBS Increases Stake Amid Innovative Drug Sector Rebound

Market Focus
·
Jul 03

Movement Alert|Luye Pharma Falls 6.91% in Regular Trading, Innovative Drug Sector Under Sustained Pressure

Market Focus
·
Jun 30

Luye Pharma: Shareholders Pass All AGM Resolutions with Overwhelming Majority, Re-Elect Directors and Renew Key Mandates

Bulletin Express
·
Jun 26

Luye Pharma Shareholders Back Share Issuance Mandate at AGM Poll

Reuters
·
Jun 26

Shandong Boan Biotech shareholders adopt restricted share unit incentive scheme at AGM

Reuters
·
Jun 22

Luye Pharma Group Drug Meets Main Goal of Phase 2 Study

MT Newswires Live
·
Jun 17

Daily Insight into Hong Kong Stocks: DeepSeek Secures $50 Billion Funding, Yum China Acquires Full Ownership of Pizza Hut in Mainland China

Stock News
·
Jun 17

LUYE PHARMA's Novel Drug LY03015 Shows Positive Phase II Results in China for Tardive Dyskinesia

Stock News
·
Jun 16

Luye Pharma reports strong Phase 2 data for first-in-class TD therapy LY03015, sets stage for global Phase 3

Bulletin Express
·
Jun 16

Luye Pharma says LY03015 meets primary endpoint in China Phase 2 tardive dyskinesia trial

Reuters
·
Jun 16

TransThera Sciences names Sun Delong chief operating officer

Reuters
·
Jun 12

Luye Pharma Group's Bond Buyback Undersubscribed

MT Newswires Live
·
Jun 12

Shandong Boan Biotech licenses U.S. rights to dulaglutide biosimilar BA5101 to partner

Reuters
·
Jun 11

Luye Pharma Completes $180 Million Convertible Bond Sale

MT Newswires Live
·
Jun 11

LUYE PHARMA Successfully Issues $180 Million Convertible Notes Due 2031

Stock News
·
Jun 11

Luye Pharma finalises US$180 million 5.25% convertible bond issue maturing 2031

Bulletin Express
·
Jun 11

Hong Kong Stocks Extend Losses Amid Middle East Flare-Up; Luye Pharma Proposes Debt Offering

MT Newswires Live
·
Jun 04

Hong Kong Market Midday Update: Hang Seng Index Down 1.4% as Semiconductor Sector Defies Broader Decline

Stock News
·
Jun 04

Luye Pharma Plans $180 Million Convertible Bond Sale, Bond Buyback

MT Newswires Live
·
Jun 04

FTSE China 50 Index Rebalance Adds GigaDevice, Pony.ai and WeRide Enter Southbound Stock Connect

Stock News
·
Jun 04